FDA issues first warning letter under DSCA for opioid distribution

McKesson Corp is back in the spotlight for opioid-related violations — this time involving rules under the 2013 Drug Supply Chain Security Act.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news